Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Risk of acute kidney injury associated with the use of fluoroquinolones
by
Etminan, Mahyar
, Hartzema, Abraham G.
, Bird, Steven T.
, Delaney, Joseph A.C.
, Brophy, James M.
in
Acute Kidney Injury - chemically induced
/ Acute renal failure
/ Adult
/ Aged
/ Aged, 80 and over
/ Anti-Bacterial Agents - adverse effects
/ Antibiotics
/ Case-Control Studies
/ Complications and side effects
/ Drug therapy
/ Fluoroquinolones - adverse effects
/ Humans
/ Kidney stones
/ Logistic Models
/ Male
/ Middle Aged
/ Quinolone antibacterial agents
/ Quinolones
/ Risk
/ Risk Assessment
/ Risk Factors
/ Studies
/ United States
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Risk of acute kidney injury associated with the use of fluoroquinolones
by
Etminan, Mahyar
, Hartzema, Abraham G.
, Bird, Steven T.
, Delaney, Joseph A.C.
, Brophy, James M.
in
Acute Kidney Injury - chemically induced
/ Acute renal failure
/ Adult
/ Aged
/ Aged, 80 and over
/ Anti-Bacterial Agents - adverse effects
/ Antibiotics
/ Case-Control Studies
/ Complications and side effects
/ Drug therapy
/ Fluoroquinolones - adverse effects
/ Humans
/ Kidney stones
/ Logistic Models
/ Male
/ Middle Aged
/ Quinolone antibacterial agents
/ Quinolones
/ Risk
/ Risk Assessment
/ Risk Factors
/ Studies
/ United States
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Risk of acute kidney injury associated with the use of fluoroquinolones
by
Etminan, Mahyar
, Hartzema, Abraham G.
, Bird, Steven T.
, Delaney, Joseph A.C.
, Brophy, James M.
in
Acute Kidney Injury - chemically induced
/ Acute renal failure
/ Adult
/ Aged
/ Aged, 80 and over
/ Anti-Bacterial Agents - adverse effects
/ Antibiotics
/ Case-Control Studies
/ Complications and side effects
/ Drug therapy
/ Fluoroquinolones - adverse effects
/ Humans
/ Kidney stones
/ Logistic Models
/ Male
/ Middle Aged
/ Quinolone antibacterial agents
/ Quinolones
/ Risk
/ Risk Assessment
/ Risk Factors
/ Studies
/ United States
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Risk of acute kidney injury associated with the use of fluoroquinolones
Journal Article
Risk of acute kidney injury associated with the use of fluoroquinolones
2013
Request Book From Autostore
and Choose the Collection Method
Overview
Case reports indicate that the use of fluoroquinolones may lead to acute kidney injury. We studied the association between the use of oral fluoroquinolones and acute kidney injury, and we examined interaction with renin–angiotensin-system blockers.
We formed a nested cohort of men aged 40–85 enrolled in the United States IMS LifeLink Health Plan Claims Database between 2001 and 2011. We defined cases as men admitted to hospital for acute kidney injury, and controls were admitted to hospital with a different presenting diagnosis. Using risk-set sampling, we matched 10 controls to each case based on hospital admission, calendar time (within 6 wk), cohort entrance (within 6 wk) and age (within 5 yr). We used conditional logistic regression to assess the rate ratio (RR) for acute kidney injury with current, recent and past use of fluoroquinolones, adjusted by potential confounding variables. We repeated this analysis with amoxicillin and azithromycin as controls. We used a case-time–control design for our secondary analysis.
We identified 1292 cases and 12 651 matched controls. Current fluoroquinolone use had a 2.18-fold (95% confidence interval [CI] 1.74–2.73) higher adjusted RR of acute kidney injury compared with no use. There was no association between acute kidney injury and recent (adjusted RR 0.87, 95% CI 0.66–1.16) or past (RR 0.86, 95% CI 0.66–1.12) use. The absolute increase in acute kidney injury was 6.5 events per 10 000 person-years. We observed 1 additional case per 1529 patients given fluoroquinolones or per 3287 prescriptions dispensed. The dual use of fluoroquinolones and renin–angiotensin-system blockers had an RR of 4.46 (95% CI 2.84–6.99) for acute kidney injury. Our case-time–control analysis confirmed an increased risk of acute kidney injury with fluoroquinolone use (RR 2.16, 95% CI 1.52–3.18). The use of amoxicillin or azithromycin was not associated with acute kidney injury.
We found a small, but significant, increased risk of acute kidney injury among men with the use of oral fluoroquinolones, as well as a significant interaction between the concomitant use of fluoroquinolones and renin–angiotensin-system blockers.
Publisher
Elsevier Inc,CMA Joule Inc,CMA Impact, Inc,Canadian Medical Association
This website uses cookies to ensure you get the best experience on our website.